Xia Z W, Zhong W W, Meyrowitz J S, Zhang Z L
Department of Pediatrics, Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, 200025, Shanghai, China.
Curr Pharm Des. 2008;14(5):454-64. doi: 10.2174/138161208783597326.
Heme oxygenase-1 (HO-1) is the rate-limiting enzyme of ferroheme metabolic pathway, which has the functions of anti-oxidation, anti-inflammatory, anti-apoptosis and anti-smooth muscle hyperplasia. Furthermore, HO-1 exerts a protective action in the diseases mediated by effector T lymphocytes such as T helper (Th) 1, Th2 and Th17. In addition, regulatory T cells (Treg) control the activity of CD4+CD25- effector cells in a suppressive manner. Numerous studies indicate that the protective action of HO-1 in diseases is through CD4+CD25+ Treg. This paper will review the current research and understanding of HO-1's role in T cells-mediated immunoregulation.
血红素加氧酶-1(HO-1)是亚铁血红素代谢途径的限速酶,具有抗氧化、抗炎、抗凋亡和抗平滑肌增生的功能。此外,HO-1在由效应T淋巴细胞介导的疾病中发挥保护作用,如辅助性T(Th)1、Th2和Th17。此外,调节性T细胞(Treg)以抑制方式控制CD4+CD25-效应细胞的活性。大量研究表明,HO-1在疾病中的保护作用是通过CD4+CD25+ Treg实现的。本文将综述目前对HO-1在T细胞介导的免疫调节中作用的研究和认识。